InogenINGN
INGN
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
115% more call options, than puts
Call options by funds: $2.11M | Put options by funds: $979K
67% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 30
20% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 20
1% more funds holding
Funds holding: 133 [Q3] → 134 (+1) [Q4]
5.15% less ownership
Funds ownership: 89.22% [Q3] → 84.08% (-5.15%) [Q4]
11% less capital invested
Capital invested by funds: $205M [Q3] → $184M (-$21.6M) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for INGN.
Financial journalist opinion
Based on 3 articles about INGN published over the past 30 days
Neutral
Business Wire
1 week ago
Inogen To Present at 24th Annual Needham Virtual Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen To Present at 24th Annual Needham Virtual Healthcare Conference.
Positive
Zacks Investment Research
2 weeks ago
Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Positive
Zacks Investment Research
3 weeks ago
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 performance and a strong product portfolio, seems justified.
Positive
Seeking Alpha
1 month ago
A Volatile Share Price Masks Some Of The Progress At Inogen
Inogen's new management and strategy are yielding results, with better-than-expected 2024 performance and a more stable base from which to keep growing the B2B business. Despite weak DTC sales, strong B2B growth drove better-than-expected sales in Q4, and Inogen likewise beat on margins. Guidance disappointed investors and prompted a 15% drop in the shares, as moderately better revenue guidance was offset by unexpected gross margin deleverage.
Positive
Benzinga
1 month ago
What's Going On With MedTech Focused Inogen Stock On Wednesday?
Medical Technology company Inogen Inc INGN reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents.
Positive
Zacks Investment Research
1 month ago
INGN Stock Gains Following Q4 Earnings Beat, Adjusted Gross Margin Up
Inogen's overall fourth-quarter 2024 results continue to gain from higher business-to-business sales.
Neutral
Seeking Alpha
1 month ago
Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript
Inogen, Inc. (NASDAQ:INGN ) Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ET Company Participants Ryan Peterson – Investor Relations Kevin Smith – President and Chief Executive Officer Mike Bourque – Chief Financial Officer Conference Call Participants Operator Welcome to Inogen's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Negative
Zacks Investment Research
1 month ago
Inogen (INGN) Reports Q4 Loss, Tops Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to loss of $1.14 per share a year ago.
Neutral
Business Wire
1 month ago
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ended December 31, 2024. “2024 was a stellar year for Inogen. With our new leadership team in place, we returned the Company to growth, achieved significant milestones, and made meaningful steps towards profitability,” said Kevin Smith, President and Chief Executive.
Positive
Zacks Investment Research
1 month ago
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
Charts implemented using Lightweight Charts™